ISSN: 2222-6990
Open access
The COVID-19 has caused many treatment facilities to close down or not operational. This has led to a decrease in the number of drug users detected which causes the population to be underreported. For policies and strategies to be implemented effectively, an accurate estimation of the population is required. This study aims to estimate the population of youth drug users in Malaysia using an indirect method of the benchmark-multiplier method. Data from the NADA’s database was used as a benchmark, and secondary data from a prevalence study was used as a multiplier. The results estimated around 654,000 individuals between the ages of 15 and 39 used drugs in 2021. This is a prevalence rate between four to five drug users for every 100 individuals within the age group. The apparent decline in the NADA yearly report could be attributed to most of the drug users being undetected primarily due to the country’s focus on the pandemic. Efforts on the issue of substance use should be increased based on the reflected number from this study. The estimates can be useful for future researchers to expand further work in estimating the population of drug users or other hidden populations.
Abdullah, M. F. I. L., Singh, D., Swogger, M. T., Rahim, A. A., & Vicknasingam, B. (2019). The prevalence of psychotic symptoms in kratom (Mitragyna speciosa Korth.) Users in Malaysia. Asian Journal of Psychiatry, 43, 197–201.
https://doi.org/10.1016/J.AJP.2019.07.008
Abdul-Quader, A. S., Baughman, A. L., & Hladik, W. (2014). Estimating the size of key populations: Current status and future possibilities. Current Opinion in HIV and AIDS, 9(2), 107–114. https://doi.org/10.1097/COH.0000000000000041
Ali, J., Hassan, S., & Abdul Karim, N. A. (2009). Kos Ekonomi Penyalahgunaan Dadah. Jurnal Antidadah Malaysia, 6(5), 107–121.
Ali, J., Sufian, A., Bakar, A., Arzemi, A., Ishak, A. N., Mohd, D., & Hashim, N. (2022). Kos Ekonomi Penagihan Dadah Di Malaysia. Jurnal Antidadah Malaysia, 14(1), 32–53.
Augustin, R., & Kraus, L. (2004). Changes in prevalence of problem opiate use in Germany between 1990 and 2000. European Addiction Research, 10(2), 61–67. https://doi.org/10.1159/000076115
Bollaerts, K., Aerts, M., & Sasse, A. (2013). Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000–10. Archives of Public Health, 71(1), 6–11. https://doi.org/10.1186/0778-7367-71-10
Chabata, S. T., Fearon, E., Webb, E. L., Weiss, H. A., Hargreaves, J. R., & Cowan, F. M. (2020). Assessing Bias in Population Size Estimates among Hidden Populations When Using the Service Multiplier Method Combined with Respondent-Driven Sampling Surveys: Survey Study. JMIR Public Health and Surveillance, 6(2). https://doi.org/10.2196/15044
EMCDDA. (1996). Estimating the prevelance of problem drug use in Europe. EMCDDA Scientific Monograph Series, 1, 270.
Handcock, M. S., Gile, K. J., & Mar, C. M. (2014). Estimating hidden population size using respondent-driven sampling data. Electronic Journal of Statistics, 8(1), 1491–1521. https://doi.org/10.1214/14-EJS923
Hiebert, L., Azzeri, A., Dahlui, M., Hecht, R., Mohamed, R., Hana Shabaruddin, F., & McDonald, S. A. (2020). Estimating the Population Size of People Who Inject Drugs in Malaysia for 2014 and 2017 Using the Benchmark-Multiplier Method. Substance Use and Misuse, 55(6), 871–877. https://doi.org/10.1080/10826084.2019.1708943
Hipp, L., & Kohler, U. (2019). How to Implement Respondent-Driven Sampling in Practice: Insights from Surveying 24-Hour Migrant Home Care Workers. https://doi.org/10.13094/SMIF-2019-00009
Ismail, R., Manaf, M. R. A., Hassan, M. R., Nawi, A. M., Ibrahim, N., Lyndon, N., Amit, N., Zakaria, E., Razak, M. A. A., Nor, N. I. Z., Shukor, M. S., & Kamarubahrin, A. F. (2022). Prevalence of Drug and Substance Use among Malaysian Youth: A Nationwide Survey. International Journal of Environmental Research and Public Health, 19(8). https://doi.org/10.3390/ijerph19084684
Jones, H. E., Harris, R. J., Downing, B. C., Pierce, M., Millar, T., Ades, A. E., Welton, N. J., Presanis, A. M., De Angelis, D., & Hickman, M. (2020). Estimating the prevalence of problem drug use from drug-related mortality data. https://doi.org/10.1111/add.15111
Jones, H. E., Welton, N. J., Ades, A. E., Pierce, M., Davies, W., Coleman, B., Millar, T., & Hickman, M. (2016). Problem drug use prevalence estimation revisited: heterogeneity in capture–recapture and the role of external evidence. Addiction, 111(3), 438–447. https://doi.org/10.1111/add.13222
Kimber, J., Hickman, M., Degenhardt, L., Coulson, T., & Van Beek, I. (2008). Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: Comparison of indirect prevalence estimation methods. Addiction, 103(10), 1604–1613. https://doi.org/10.1111/J.1360-0443.2008.02276.X
Kraus, L., Augustin, R., Frischer, M., Kümmler, P., Uhl, A., & Wiessing, L. (2003). Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction, 98(4), 471–485. https://doi.org/10.1046/j.1360-0443.2003.00326.x
Kwon, J. A., Iversen, J., Law, M., Dolan, K., Wand, H., & Maher, L. (2019). Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016. Drug and Alcohol Dependence, 197, 108–114.
https://doi.org/10.1016/j.drugalcdep.2018.11.033
Larney, S., Hickman, M., Guy, R., Grebely, J., Dore, G. J., Gray, R. T., Day, C. A., Kimber, J., & Degenhardt, L. (2017). Estimating the number of people who inject drugs in Australia. BMC Public Health, 17(1), 1–7. https://doi.org/10.1186/s12889-017-4785-7
Leclerc, P., Vandal, A. C., Fall, A., Bruneau, J., Roy, É., Brissette, S., Archibald, C., Arruda, N., & Morissette, C. (2014). Estimating the size of the population of persons who inject drugs in the island of Montréal, Canada, using a six-source capture–recapture model. Drug and Alcohol Dependence, 142, 174–180.
https://doi.org/10.1016/j.drugalcdep.2014.06.022
Mojtabai, R. (2022). Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method. JAMA Psychiatry, 79(11), 1074–1080. https://doi.org/10.1001/JAMAPSYCHIATRY.2022.2756
National Anti-Drugs Agency. (2015). Dasar Dadah Negara (Issue 1). Agensi Anti Dadah Kebangsaan. http://www.adk.gov.my/html/pdf/Buletin/dasardadahnegara.pdf
National Anti-Drugs Agency. (2021). Information on Drugs 2021.
National Institute of Health, & Ministry of Health Malaysia. (2019). National Health Morbidity Survey 2019.
Peiper, N. C., Ridenour, T. A., Hochwalt, B., & Coyne-Beasley, T. (2016). Overview on Prevalence and Recent Trends in Adolescent Substance Use and Abuse. In Child and Adolescent Psychiatric Clinics of North America (Vol. 25, Issue 3, pp. 349–365). https://doi.org/10.1016/j.chc.2016.03.005
Pisani, E., Weir, S., Zaba, B., & Hay, G. (2003). Estimating the size of populations at risk for HIV: Issues and Methods (Updated July 2013). In UNAIDS/ WHO Working Group on HIV/AIDS/STI Surveillance. https://www.popline.org/node/251109
Ruiz, M. S., O’Rourke, A., & Allen, S. T. (2016). Using Capture-Recapture Methods to Estimate the Population of People Who Inject Drugs in Washington, DC. AIDS and Behavior, 20(2), 363–368. https://doi.org/10.1007/s10461-015-1085-z
Salganik, M. J., & Heckathorn, D. D. (2004). 5. Sampling and Estimation in Hidden Populations Using Respondent-Driven Sampling. Sociological Methodology, 34(1), 193–240. https://doi.org/10.1111/j.0081-1750.2004.00152.x
Sweeting, M. J., De Angelis, D., Ades, A. E., & Hickman, M. (2009). Estimating the prevalence of ex-injecting drug use in the population. Statistical Methods in Medical Research, 18(4), 381–395. https://doi.org/10.1177/0962280208094704
UNDCP. (2002). In-direct methods for estimating the size of the drug problem. In GAP Toolkit Module 3: Prevalence Estimation (Issue November). www.undcp.org.
UNODC. (2023). World Drug Report 2023. www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html
Vaissade, L., & Legleye, S. (2009). Capture–recapture estimates of the local prevalence of problem drug use in six French cities. European Journal of Public Health, 19(1), 32–37. https://doi.org/10.1093/eurpub/ckn126
N/A
Copyright: © 2023 The Author(s)
Published by HRMARS (www.hrmars.com)
This article is published under the Creative Commons Attribution (CC BY 4.0) license. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this license may be seen at: http://creativecommons.org/licences/by/4.0/legalcode